ARTICLE | Company News
Eli Lilly, Cerecor deal
March 9, 2015 7:00 AM UTC
Eli Lilly granted Cerecor exclusive, worldwide rights to develop and commercialize CERC-501. The kappa opioid receptor ( KOR; OPRK1) antagonist has completed Phase I testing to treat depression and...